ABSTRACT

   Typhoid fever (TF) is an acute systemic infection caused by Salmonella Typhi, Salmonella Para Typhi A and Salmonella Para Typhi B. It is transmitted by the fecal oral route mainly via contaminated food and water. The developing countries have high rate of morbidity and mortality due to Typhoid fever, epidemics take place in developed world also. There are increased incidences of multi drug resistant in S. typhi strains that has further complicated its management and only a few antibiotics are now effective in treatment of typhoid. We report that the aqueous extracts of fruit peel Citrus sinensis (L.) confer anti typhoid activity against Salmonella Typhi, Salmonella Para Typhi A and Salmonella Para Typhi B respectively on comparison with ciprofloxacin.



        

Key words:
Typhoid fever, Salmonella Typhi, Salmonella Para Typhi A , Salmonella Para Typhi B, anti typhoid activity, Citrus sinensis.
Copyright © 2009  by "International Journal of Pharmaceutica Research and Development"  ·  All Rights reserved  ·  E-Mail: info@ijprd.com
Welcome to "International Journal of Pharmaceutical Research and Development"  i.e. "IJPRD"
HOW TO PREPARE   
YOUR PAPER
What's New | Feedback | Copyright and Disclaimer
Online Since : March 2009
TODAY IS
Abstract Content
Model Abstract
Summary Content
Model Summary

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT
Current & Important Pharma News 
HC stay on immediate withdrawal of banned drugs

Drug manufacturers in the country have secured a stay from the Madras High Court over immediate withdrawal of two banned drugs — pediatric doses of pain reliever nimesulide and anti-cold medicine phenylpropanolamine — from the domestic market.

The ban on manufacturing the drugs will continue. The stay will be in effect until March 31, the next date of hearing.

Despite the HC stay, the health ministry has — through print advertisements — demanded immediate withdrawal of these two medicines from drug retail shelves.

The HC intervention happened after Indian Drugs Manufacturers Association (IDMA) and the Confederation of Indian Pharmaceutical Industries moved a petition challenging the government decision for immediate withdrawal of medicines that have been in the market for 40 years.

Drug traders said there were over 1,000 brands of pain relief drug that would have to be removed from the shelves due to the ban. The size of the market for the banned drugs is not significant. An IDMA functionary said the association was only seeking more time to liquidate the stocks of medicines that had been in the market for a long period. “We have been granted two weeks to liquidate the stocks. Normally, it takes 45-60 days and we hope to secure another extension,” he said.

In a notification issued on February 10, the ministry said pediatric use of nimesulide and the use of medicines such as Cisapride, PPA, human placental extract based drugs, Sibutramine had been banned with immediate effect, as all these medicines were found to be having harmful side effects.

Almost all these medicines are either banned or highly restricted in most developed markets with strict drug regulatory system in place. Recently, the ministry announced the ban of two more medicines — gatifloxacine and tegaserod.


Ref :  http://www.business-standard.com/india/news/hc-stayimmediate-withdrawalbanned-drugs/429458/
List of banned drug in India - Visit Central Drugs Standard Control Organizations Website - http://www.cdsco.nic.in/